AUS
NZ
UK
CA
USA
IND
Healthcare
iRhythm's Zio Monitor Enhances Performance with Latest Study Findings
September 10, 2024 12:02 PM PDT| By Team Kalkine MediaHeadlines,- iRhythm Technologies,(NASDAQ:IRTC),has unveiled promising results from the latest research on its Zio LTCM monitor, highlighting significant improvements in device performance.,- The Zio LTCM monitor, featuring a new design with a waterpr...
Intrinsic Value Examination of 111 Inc. Reveals Current Market Insights
September 10, 2024 09:43 AM PDT| By Team Kalkine MediaIn the,Healthcare sector,, 111 Inc. has recently been evaluated to understand its intrinsic value and current market position. This sector, known for its dynamic nature and shifting consumer preferences, is vital in assessing how well companies like...
Accuray’s Journey: Key Milestones on the Road to Breakeven
September 10, 2024 09:42 AM PDT| By Team Kalkine MediaIn the,healthcare sector,, Accuray Incorporated is a notable company engaged in the development and delivery of advanced radiation oncology systems. This sector, characterized by its focus on medical technology and innovation, is crucial for understa...
Spectral AI Showcases Its Wound Care Device to Address Gaps in Burn Treatment
September 10, 2024 09:20 AM PDT| By Team Kalkine MediaSpectral AI Inc.,(NASDAQ:MDAI),has underscored the role of its DeepView System in addressing disparities in burn care access, as highlighted by a recent report from the American Burn Association (ABA). The report, featured in the January/February 202...
Futura Medical Reports Maiden Profit and Outlook
September 10, 2024 03:43 AM PDT| By Team Kalkine MediaFutura Medical PLC, a player in the,healthcare sector,, has announced a notable achievement with its first-ever profit. For the first half of 2024, the company reported a profit of £1 million on revenue of £7 million. The company concluded this perio...
Qualigen Therapeutics (NASDAQ: QLGN) Raises $3.47 Million Through Public Offering, Plans Accelerated Debt Repayment and Expansion
September 08, 2024 11:11 PM PDT| By Team Kalkine MediaQualigen Therapeutics, Inc. (NASDAQ: QLGN) has successfully closed its public offering of 14,724,058 shares of common stock, priced at $0.13 per share. The offering also included pre-funded warrants to purchase up to 11,972,754 additional shares at a...
VistaGen Therapeutics Gains Momentum with Rating Upgrade
September 06, 2024 06:34 PM PDT| By Team Kalkine MediaHeadlines,- VistaGen Therapeutics,(NASDAQ:VTGN),has received a recent rating upgrade, reflecting positive shifts in its earnings outlook.,- Rising earnings estimates are linked to increased interest from institutional investors, which can impact shar...
Ocuphire Pharma (Nasdaq:OCUP) Initiates VEGA-3 Phase 3 Trial for Presbyopia Treatment
September 05, 2024 09:28 PM PDT| By Team Kalkine MediaOcuphire Pharma, Inc. (Nasdaq:OCUP), a clinical-stage biopharmaceutical company specializing in ophthalmic treatments, has announced the commencement of its VEGA-3 Phase 3 clinical trial. The trial is evaluating Phentolamine Ophthalmic Solution 0.75%...
Health Insurer Stocks Face Decline Amid Medicaid Enrollment Challenges
September 04, 2024 01:09 PM PDT| By Team Kalkine MediaHeadlines,- Health insurer stocks declined following concerns raised by Centene about Medicaid enrollments.,- Centene's CEO highlighted ongoing challenges with Medicaid eligibility redetermination.,- Medicaid enrollments have significantly decreased...
Keytruda and Padcev Combo Secures EU Approval for Bladder Cancer Treatment
September 04, 2024 12:19 PM PDT| By Team Kalkine MediaHeadlines,The European Commission has approved the Keytruda and Padcev combination for treating advanced urothelial carcinoma.,The approval follows positive data from the phase III KEYNOTE-A39 study and earlier recommendations from European medical a...
Vaxcyte Hits Record High with Promising Pneumococcal Vaccine Results
September 04, 2024 12:17 PM PDT| By Team Kalkine MediaHeadlines,Breakthrough Study Results:,Vaxcyte's stock surged over 36% after announcing positive results from a Phase I/II trial of its 31-valent pneumococcal conjugate vaccine, VAX-31. The vaccine demonstrated strong immune responses across multiple...
Ensign Expands with New Facilities in Kansas and Colorado
September 04, 2024 12:16 PM PDT| By Team Kalkine MediaHeadlines,New Facility Acquisitions:,Ensign Group, Inc. has recently expanded its operations by adding a nursing facility in Overland Park, Kansas, and acquiring seven additional facilities across Colorado.,Growth in Footprint:,The new additions incl...
_09_04_2024_18_33_40_018044.jpg)
Beam Maintains Cash Position Despite Current Burn Rate
September 04, 2024 11:32 AM PDT| By Team Kalkine MediaBeam Therapeutics, operating within the,Healthcare sector,, has recently addressed concerns regarding its financial stability amid its current cash burn rate. As a company focused on advancing gene-editing therapies, Beam Therapeutics has provided re...
Exciting Biotech Opportunity: Explore Viking Therapeutics for Potential Growth
September 03, 2024 12:17 PM PDT| By Team Kalkine MediaHeadlines,Innovative Research:,Viking Therapeutics has shown significant potential with its promising weight loss treatment, VK2735, which is advancing to phase 3 trials.,Strong Financial Position,: The company boasts a robust financial standing with...
Amneal Pharmaceuticals Surges 29% Amid Key FDA Approvals and Strong Q2 Performance
September 03, 2024 12:14 PM PDT| By Team Kalkine MediaHeadlines,Amneal Pharmaceuticals' shares rose 29% in the past month following multiple FDA approvals, including a novel Parkinson's disease treatment.,The company achieved robust revenue growth in Q2 2024, driven by new product launches and increased...
Two Resilient Dividend Payers for Economic Uncertainty
September 02, 2024 04:41 PM PDT| By Team Kalkine MediaHeadlines,Healthcare's Resilience: AbbVie and Merck, two prominent pharmaceutical companies, are well-positioned to navigate economic downturns due to their essential products and robust pipelines.,AbbVie's Strategic Growth: AbbVie continues to perfo...
Cathie Wood's Strategic Moves: 3 Companies She Invested In
August 30, 2024 12:34 PM PDT| By Team Kalkine MediaHeadlines,Cathie Wood recently expanded her positions in Tempus AI, Blade Air Mobility, and Absci, signaling her focus on innovative technologies in healthcare and transportation.,Tempus AI has shown strong growth since its IPO, with a promising futu...
Alphatec Faces Challenges Despite Positive Sentiment
August 30, 2024 08:26 AM PDT| By Team Kalkine MediaIn recent developments within the,healthcare sector,, Alphatec Holdings, Inc. continues to grapple with challenges, despite experiencing some positive sentiment. The company's current financial and operational situation has attracted attention as it...
_08_30_2024_15_24_26_992096.jpg)
Globus Medical Reports Positive Financial Results
August 30, 2024 08:23 AM PDT| By Team Kalkine MediaIn recent developments within the,healthcare sector,, Globus Medical, Inc. has announced a significant financial performance update. The company’s recent financial results have shown promising performance, reflecting positively on its operations and...
How GeneDx Manages Debt and Its Financial Impact
August 29, 2024 06:13 PM PDT| By Team Kalkine MediaIn the,healthcare sector,, GeneDx Holdings, a company specializing in genetic and genomic testing services, is under scrutiny regarding its use of debt. Recent assessments focus on whether the company is managing its debt obligations effectively and...
